Novo Nordisk, the Danish pharmaceutical company behind the blockbuster weight-loss drug Wegovy, has confirmed that patient data from some of its clinical trials was accessed and copied without authorization from its internal IT systems in a recent cyberattack. The company disclosed the incident in a public statement and said it has launched an investigation with […] The post Novo Nordisk cyberattack, What’s at stake? appeared first on Rolling Out .
Get in touch with us
Reach out to the Hayti team about
collaborating or working together.



